NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
1 hedge funds and large institutions have $2.7K invested in NexImmune, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
92% less funds holding
Funds holding: 13 → 1 (-12)
99% less capital invested
Capital invested by funds: $409K → $2.7K (-$406K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$138K |
| 2 |
SPC
Slate Path Capital
New York
|
-$102K |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$43.1K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$34.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
1
Raymond James & Associates
St Petersburg,
Florida
| $2.7K | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| – | -$138K | -49,904 | Closed |
|
|
SPC
3
Slate Path Capital
New York
| – | -$102K | -36,999 | Closed |
|
|
ECG
4
EPIQ Capital Group
San Francisco,
California
| – | -$43.1K | -15,624 | Closed |
|
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$34.9K | -12,640 | Closed |
|
|
6
Vanguard Group
Malvern,
Pennsylvania
| – | -$33.1K | -12,010 | Closed |
|
7
JP Morgan Chase
New York
| – | -$11.1K | -4,000 | Closed |
|
8
Comerica Bank
Dallas,
Texas
| – | -$8.99K | -3,256 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$5.85K | -2,121 | Closed |
|
10
UBS Group
Zurich,
Switzerland
| – | -$1.76K | -638 | Closed |
|
11
BNP Paribas Financial Markets
Paris,
France
| – | -$113 | -41 | Closed |
|
12
Bank of America
Charlotte,
North Carolina
| – | -$19 | -7 | Closed |
|
NEXI Hedge Fund Activity: Q3 2024 in Review
1 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2024, worth a combined $2.7K — down 99% from $409K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NEXI and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $138K sold.
- 1 institutional investor held NexImmune, Inc. Common Stock (NEXI) as of Q3 2024, down from 13 in Q2 2024.
- Funds reported $2.7K of NexImmune, Inc. Common Stock stock for Q3 2024, down 99% quarter-over-quarter.
- 0 funds opened new NexImmune, Inc. Common Stock positions in Q3 2024 and 12 closed out, a net change of -12 holders.
- The largest NexImmune, Inc. Common Stock seller in Q3 2024 was Sabby Management, an estimated $138K sold.
Based on aggregated 13F filings for Q3 2024.